Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis

Acta Oto-Laryngologica

Volumn 119, Issue 2, 1999, Pages 281-284

  Heimdal, John Helge ^a   Aarstad, Hans Jørgen ^a   Klementsen, Beate ^a   Olofsson, Jan ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Prognosis; Squamous cell carcinoma; T lymphocyte; TNM stage

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HEAD CANCER; HUMAN; IMMUNE SYSTEM; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NECK CANCER; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; T-LYMPHOCYTES;

EID: 0032952749     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016489950181828     Document Type: Article

References (17)

1. Dunn PL, North RJ. Adoptive immunotherapy of established tumors. Acquisition of radioresistance by tumor-specific T-cells after passive transfer into tumor-bearing recipients. Int J Cancer 1994; 57: 592-7.
2. Yasumura S, Hirabayashi H, Schwartz DR, et al. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Cancer Res 1993; 53: 1461-8.
3. Cederholm T, Wretlind B, Hellström K, et al. Enhanced generation of interleukins 1 beta and 6 may contribute to the cachexia of chronic disease. Am J Clin Nutr 1997; 65: 876-82.
4. Clayman GL, Young G, Taylor DL, Savage HE, Lavedan P, Schantz SP. Detection of regulatory factors of lymphokine-activated killer cell activity in head and neck cancer patients treated with interleukin-2 and interferon alpha. Ann Otol Rhinol Laryngol 1992; 101: 909-15.
5. Heimdal JH, Aarstad HJ, Aakvaag A, Olofsson J. In vitro T-lymphocyte function in head and neck cancer patients. Eur Arch Otorhinolaryngol 1997; 254: 318-22.
6. Noguchi Y, Yoshikawa T, Matsumoto A, Svaninger G, Gelin J. Are cytokines possible mediators for cancer cachexia? Surg Today 1996; 26: 467-75.
7. Jones GW, Browman G, Goodyear M, Marcellus D, Hodson DI. Comparison of the addition of T and N integer scores with TNM stage groups in head and neck cancer. Head Neck 1993; 15: 497-503.
8. Vlock DR. Immunobiologic aspects of head and neck cancer. Clinical and laboratory correlates. Hematol Oncol Clin North Am 1991; 5: 797-820.
9. Bettinger R, Knecht R, Lorz M, von-Ilberg C. Untersuchungen über tumorassoziierte Makrophagen (TAM) im Stroma von Plattenephitelkarzinomen des HNO-Bereiches mit Hilfe von monoklonalen Antikorpern. Laryngorhinootologie 1990; 69: 631-5.
10. Stankiewicz C. Prognostic significance of lymph node reactivity in patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 1994; 251: 418-22.
11. Huang AT, Mold NG, Fisher SR, et al. A prospective study of squamous head and neck carcinoma. Immunologic aberrations in patients who develop recurrent disease. Cancer 1987; 59: 1721-6.
12. Hilal EY, Wanebo HJ, Pinsky CM, Middleman P, Strong EW, Oettgen HF. Immunologic evaluation and prognosis in patients with head and neck cancer. Am J Surg 1977; 134: 468-73.
13. Yamanaka N. Immunomodulatory serum components in head and neck cancer. Oral Oncology. Eur J Cancer 1993; 29B: 103-6.
14. UICC International Union Against Cancer. Hermanek P, Sobin LH, eds. TNM Classification of malignant tumours, 4th edn, 2nd revision. 1992, Springer-Verlag, Berlin.
15. Husband AJ. Role of central nervous system and behavior in the immune response. Vaccine 1993; 11: 805-16.
16. Martinez F, Abril ER, Earnest DL, Watson RR. Ethanol and cytokine secretion. Alcohol 1992; 9: 455-8.
17. Mili F, Flanders WD, Boring JR, Annest JL, Destefano F. The associations of race, cigarette smoking, and smoking cessation to measures of the immune system in middle-aged men. Clin Immunol Immunpathol 1991; 59: 187-200.